![]() |
|
|
Molecular Pharmacology, Vol 5, 342-349, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Biochemistry, Duke University Medical Centre,
Durham, North Carolina 27706
Dopamine
-hydroxylase (EC 1.14.2.1) was used as a marker to follow the fate of the
adrenal storage vesicles following the release of adrenaline. Neurogenic secretion of adrenaline induced by insulin produced a decrease in the adrenaline and dopamine
-hydroxylase
contents of the gland. There was only a slight decrease in the enzyme activity of the particulate fraction obtained from lysed storage vesicles, but a marked decrease in the activity
of the soluble fraction. Twenty-four hours after the administration of reserpine (1 mg/kg)
to rabbits, changes in the dopamine
-hydroxylase activity were similar to those observed
after insulin treatment, but the glands were more severely depleted of their catecholamines.
After lower doses of reserpine (0.25 mg/kg), or if ganglionie transmission was blocked by
chlorisondamine 1 hr prior to the administration of reserpine (1 mg/kg), there were significant decreases in the catecholamine content but no changes in the dopamine
-hydroxylase
activity. These findings indicate that neurogenic secretion is characterized by release of the
soluble content of the storage vesicles directly to the exterior of the cell and retention of
the storage vesicle membranes within the cell. Interference only with time uptake or storage
mechanism by reserpine results in depletion of the catecholamine content, but not of the
intravesicular protein.